InterventionsHuman trial
Laroprovstat (AZD0780) an oral, small molecule PCSK9 inhibitor demonstrates improvements in the lipid profile in participants with hypercholesterolemia: Results from a Phase 1 study
AHA Scientific Sessions 2025 Abstract
The paper
Vega R, Yu H, Barbour A et al.
AHA Scientific Sessions 2025 Abstract · 3 Nov 2025
Presented at AHA Scientific Sessions 2025 · Abstract 4364312